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wheat-dependent exercise-induced anaphylaxis sensitized with
hydrolyzed wheat proteinTable 1
Distribution of the 40 cases with HWP-WDEIA by sex, age, serum total IgE, and RAST
score for wheat, gluten and u-5gliadin.
Characteristics N
Sex Female 44
Male 3
Age (years) <20 1
21e30 3
31e39 11
41e49 11
51e60 11
>60 10
Serum total IgE (IU/mL) &170 35
170e500 8
501e1000 2
S1000 2
RAST score Class Wheat
0e1 32
2e3 11
S4 1
Missing 1
Class Gluten
0e1 28
2e3 18
S4 1
Missing 0
Class u-5gliadin
0e1 42
2e3 2Dear Editor,
In Japan, substantial interest has recently focused on wheat-
dependent exercise-induced anaphylaxis (WDEIA) caused by
percutaneous and/or rhino-conjunctival sensitization of hydro-
lyzed wheat protein (HWP), Glupearl 19S®, which was used as
ingredient of popular facial soap of which 46 million units had
been sold. To date, more than 2000 people in Japan have been diag-
nosed with HWP-sensitized WDEIA (HWP-WDEIA).1e3 Apart from
the sensitization pathway, patients with HWP-WDEIAmanifest var-
iable levels of immediate-type response following natural wheat
product ingestion and exercise, which is quite similar to conven-
tional WDEIA.1e3 Although some genetic factors may be respon-
sible for the manifestation of WDEIA, its pathomechanism
remains largely unknown. WDEIA is a rare disease in our country
but we have encountered some patients with near-fatal anaphy-
lactic reactions. Therefore this mechanism and genetic factors asso-
ciated with the risk for WDEIA should be investigated.
It has been reported that the angiotensin-converting enzyme
(ACE) genotype was associated with cardiovascular, thrombotic
and metabolic disorders.4e6 Very recently, the ACE genotype was
implicated in the manifestation of anaphylactic reactions to food,
venom, and drugs.7 The ACE gene, located at chromosome
17q23.3, has two allelic forms, with the presence (I) or absence
(D) of a 287-base-pair intron. The II and ID genotypes are signiﬁ-
cantly more common than DD in patients with anaphylaxis, with
odds ratios (ORs) of 44 and 5.6, respectively.7 DD genotypes has
been reported as a risk factor of coronary heart disease and an ef-
fect modiﬁer of its therapeutic effect.4e6
In the present study, we examined the ACE genotypes of 47
HWP-WDEIA patients with a median age of 46.3 (range 16e75).
The allergologic data of the patients are shown in Table 1. We iso-
lated DNA from the patients' oral mucosa with the DNeasy Blood
&Tissue Kit® (Qiagen KK, Tokyo, Japan), and ampliﬁed it by PCR.
Samples were genotyped using the quenching probe method for
a single-nucleotide polymorphism (rs4341). Allele frequency of
the cases with WDEIA followed the HardyeWeinberg equilibrium
(p ¼ 0.88). The genotypes for WDEIA patients are shown in Table
2, along with the previously published data in a prospective
population-based cohort study for 2125 subjects aged 40 or older
Japanese living in the town of Hisayama, a suburban community
in Fukuoka prefecture, and participating in periodic health check-Peer review under responsibility of Japanese Society of Allergology.
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licenses/by-nc-nd/4.0/).ups.4 We examined the association between the genotypes and
the risk of having WDEIA using this general population as a control
group. Logistic regression analysis with a statistical software,
STATA, revealed an increased risk for HWP-WDEIA in individuals
with the ID genotype (OR ¼ 1.71, 95% conﬁdence interval
(CI) ¼ 0.50e5.88) and in those with the II genotype (OR ¼ 2.75,
95% CI ¼ 0.83e9.12), compared with those with DD (p for
trend ¼ 0.04). Persons with more I allele had a greater risk than
those with less I allele although the two point estimates of the
risk were not signiﬁcant.S4 2
Missing 2
RAST, radioallergosorbent test.
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Table 2
Genotypes of the ACE gene in cases with WDEIA and the general population.
HWP-WDEIA General populationy
II-ACE 27 (57.4%) 918 (43.2%)
ID-ACE 17 (36.2%) 927 (43.6%)
DD-ACE 3 (6.4%) 280 (13.2%)
Total 47 2125
HWP, hydrolyzed wheat protein; WDEIA, wheat-dependent exercise-induced
anaphylaxis.
y Quoted from a published study.4
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possible association between ACE genotypes and the risk of HWP-
WDEIA. ACE plays a key role in the circulating renineangiotensin
system through converting angiotensin I to angiotensin II. Another
important action of ACE is to degrade bradykinin to inactive pep-
tides.7 Bradykinin induces endothelial nitric oxide (NO) production
and has been implicated in the development of anaphylaxis, such as
hypotension and mucosal swelling. Findings have suggested that
bradykinin and NO are involved in angioedema, which is mediated
by ACE inhibitors.7e9 Since aerobic exercise increases the interstitial
concentration of bradykinin and neuronal NO release, exercise may
enhance the onset of WDEIA. As the production of ACE is up-
regulated in theDDgenotype comparedwith that in the ID and II ge-
notypes,10 the degradation of bradykinin tends to be accelerated in
individuals with the DD genotype.7e9 These ﬁndings may explain
why individuals with the II or ID genotype are more susceptible to
HWP-WDEIA. There are large differences in the reported I/D fre-
quencies between studies and countries.11 Those different allele fre-
quencies might be related to the different prevalence of WDEIA
between countries. Because the present study were small in size, it
should be desirable to extend the present analysis in collaboration
with other institutes in order to have more reliable estimates of
the risk due to the genetic polymorphism based on a larger data
set. Furthermore a comprehensive genetic examination by use of
genome-wide association studies for other polymorphisms may
identify other candidate genes.Acknowledgements
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